SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-23-136606
Filing Date
2023-05-05
Accepted
2023-05-05 08:17:59
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d447227dsc14d9.htm SC 14D9 419598
2 EX-99.(A)(9) d447227dex99a9.htm EX-99.(A)(9) 5168
3 GRAPHIC g447227g25d51.jpg GRAPHIC 41079
4 GRAPHIC g447227g91f74.jpg GRAPHIC 50354
  Complete submission text file 0001193125-23-136606.txt   545111
Mailing Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filed by) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-91126 | Film No.: 23891395
SIC: 2834 Pharmaceutical Preparations